Q4 2018 Vascular Biogenics Ltd Earnings Call Transcript
Greetings and welcome to the VBL Therapeutics Full Year 2018 Earnings Call. (Operator Instructions)
It is now my pleasure to introduce your host, Michael Wood of LifeSci Advisors. Thank you. You may begin.
Thank you, operator, and thank you all for participating in today's full year 2018 results and corporate update conference call. Leading the call today will be Dr. Dror Harats, CEO of VBL Therapeutics; and Amos Ron, the company's CFO. Erez Feige, VP of Business Operations, is also on the call. A press release with the company's financial results became available this morning on the Newswire that can be found on the investor relations page of the company's Web site at vblrx.com.
Before we begin, I'd like to remind everyone that various remarks about future expectations, plans, and prospects constitute forward-looking statements for the purposes of the Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995. VBL cautions that these forward-looking statements are subject to risks
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |